Literature DB >> 31159625

Personalizing surgical margins in retroperitoneal sarcomas: an update.

Brittany Dingley1, Marco Fiore1, Alessandro Gronchi2.   

Abstract

Introduction: Tumor biology, as well as completeness of surgical resection, are two important prognostic factors when treating retroperitoneal sarcoma (RPS). A frontline extended surgical approach is associated with improved local control and possibly improved survival. However, this approach has to be tailored to each histological subtype, as the patterns of growth and recurrence risks vary significantly among them. Areas covered: We provide a review of the literature in RPS, describing the behavior of each of the five main histologic subtypes: well-differentiated liposarcoma (WDLPS), dedifferentiated liposarcoma (DDLPS), leiomyosarcoma (LMS), solitary fibrous tumor (SFT) and malignant peripheral nerve sheath tumor (MPNST). The prognostic factors relevant to oncologic outcomes of RPS, the role of margins and the importance of local control are discussed. Finally, a histologic specific surgical approach to RPS is provided in detail. Expert opinion: While tumor-related factors are paramount, the only intervenable predictive factor is extent and quality of surgery. The extended surgical approach has been advocated for previously and again we describe it in more detail, tailored specifically to the tumor subtype. The aim of this approach is to maximize the possibility of achieving a complete resection through a standardized approach based on histologic behavior and site of origin.

Entities:  

Keywords:  Leiomyosarcoma; extended resection; liposarcoma; malignant peripheral nerve sheath tumor; outcome; pelvic sarcoma; prognosis; retroperitoneal sarcoma; sarcoma; solitary fibrous tumor; surgery; surgical margins

Mesh:

Year:  2019        PMID: 31159625     DOI: 10.1080/14737140.2019.1625774

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  11 in total

1.  Inoperable Primary Retroperitoneal Sarcomas: Clinical Characteristics and Reasons Against Resection at a Single Referral Institution.

Authors:  Andraz Perhavec; Salvatore Provenzano; Marco Baia; Claudia Sangalli; Carlo Morosi; Marta Barisella; Chiara Colombo; Stefano Radaelli; Sandro Pasquali; Dario Callegaro; Alessandro Gronchi; Marco Fiore
Journal:  Ann Surg Oncol       Date:  2020-07-06       Impact factor: 5.344

Review 2.  [Retroperitoneal soft tissue sarcoma: surgical management].

Authors:  Franziska Willis; Martin Schneider
Journal:  Chirurg       Date:  2021-10-01       Impact factor: 0.955

Review 3.  Management of Locally Recurrent Retroperitoneal Sarcoma in the Adult: An Updated Consensus Approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group.

Authors:  William W Tseng; Carol J Swallow; Dirk C Strauss; Sylvie Bonvalot; Piotr Rutkowski; Samuel J Ford; Ricardo J Gonzalez; Rebecca A Gladdy; David E Gyorki; Mark Fairweather; Kyo Won Lee; Markus Albertsmeier; Winan J van Houdt; Magalie Fau; Carolyn Nessim; Giovanni Grignani; Kenneth Cardona; Vittorio Quagliuolo; Valerie Grignol; Jeffrey M Farma; Elisabetta Pennacchioli; Marco Fiore; Andrew Hayes; Dimitri Tzanis; Jacek Skoczylas; Max L Almond; John E Mullinax; Wendy Johnston; Hayden Snow; Rick L Haas; Dario Callegaro; Myles J Smith; Toufik Bouhadiba; Anant Desai; Rachel Voss; Roberta Sanfilippo; Robin L Jones; Elizabeth H Baldini; Andrew J Wagner; Charles N Catton; Silvia Stacchiotti; Khin Thway; Christina L Roland; Chandrajit P Raut; Alessandro Gronchi
Journal:  Ann Surg Oncol       Date:  2022-06-29       Impact factor: 4.339

Review 4.  Landmark Series: A Review of Landmark Studies in the Treatment of Primary Localized Retroperitoneal Sarcoma.

Authors:  Megan Delisle; David Gyorki; Sylvie Bonvalot; Carolyn Nessim
Journal:  Ann Surg Oncol       Date:  2022-09-10       Impact factor: 4.339

5.  A novel nomogram model to predict the overall survival of patients with retroperitoneal leiomyosarcoma: a large cohort retrospective study.

Authors:  Chao Huang; Qiu-Ping Yu; Hao Li; Zichuan Ding; Zongke Zhou; Xiaojun Shi
Journal:  Sci Rep       Date:  2022-07-13       Impact factor: 4.996

6.  The Role of Surgical Expertise and Surgical Access in Retroperitoneal Sarcoma Resection - A Retrospective Study.

Authors:  P Aeschbacher; A Kollár; D Candinas; G Beldi; A Lachenmayer
Journal:  Front Surg       Date:  2022-05-12

7.  Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group.

Authors:  Carol J Swallow; Dirk C Strauss; Sylvie Bonvalot; Piotr Rutkowski; Anant Desai; Rebecca A Gladdy; Ricardo Gonzalez; David E Gyorki; Mark Fairweather; Winan J van Houdt; Eberhard Stoeckle; Jae Berm Park; Markus Albertsmeier; Carolyn Nessim; Kenneth Cardona; Marco Fiore; Andrew Hayes; Dimitri Tzanis; Jacek Skoczylas; Samuel J Ford; Deanna Ng; John E Mullinax; Hayden Snow; Rick L Haas; Dario Callegaro; Myles J Smith; Toufik Bouhadiba; Silvia Stacchiotti; Robin L Jones; Thomas DeLaney; Christina L Roland; Chandrajit P Raut; Alessandro Gronchi
Journal:  Ann Surg Oncol       Date:  2021-04-14       Impact factor: 4.339

8.  Advances in soft-tissue sarcoma - There are no mistakes, only lessons to learn!

Authors:  Sameer Rastogi; Parisa Manasa; Aditi Aggarwal; Kaushal Kalra
Journal:  South Asian J Cancer       Date:  2019 Oct-Dec

Review 9.  Retroperitoneal Sarcoma Care in 2021.

Authors:  Erika Schmitz; Carolyn Nessim
Journal:  Cancers (Basel)       Date:  2022-03-02       Impact factor: 6.639

10.  A systematic review of margin status in retroperitoneal liposarcomas: Does the R0 margin matter?

Authors:  Benjamin Paik; Chin Jin Seo; Joey Wee-Shan Tan; Wen Kai Darryl Juan; Khee Chee Soo; Chin-Ann Johnny Ong; Claramae Shulyn Chia; Jolene Si Min Wong
Journal:  Front Oncol       Date:  2022-08-11       Impact factor: 5.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.